Immunovant (IMVT) News Today $16.42 -0.53 (-3.13%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IMVT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Immunovant, Inc. (NASDAQ:IMVT) Given Average Recommendation of "Moderate Buy" by AnalystsJuly 7 at 2:33 AM | americanbankingnews.comImmunovant, Inc. (NASDAQ:IMVT) Receives Average Recommendation of "Moderate Buy" from BrokeragesJuly 7 at 2:30 AM | marketbeat.comLifeSci Capital Maintains a Buy on Immunovant (IMVT) With a $50 PTJuly 6 at 10:41 AM | msn.comImmunovant, Inc. (IMVT) - Yahoo FinanceJune 24, 2025 | finance.yahoo.comZacks Research Comments on Immunovant FY2028 EarningsJune 23, 2025 | marketbeat.comTracking Baker Brothers Portfolio - Q1 2025 UpdateJune 17, 2025 | seekingalpha.comImmunovant: Navigating The Complexities Of The FcRn Landscape (Downgrade)June 13, 2025 | seekingalpha.comImmunovant, Inc. (NASDAQ:IMVT) Receives Consensus Rating of "Moderate Buy" from BrokeragesJune 12, 2025 | marketbeat.comBrokers Set Expectations for Immunovant FY2027 EarningsJune 10, 2025 | marketbeat.comImmunovant (NASDAQ:IMVT) Stock Price Down 4.7% - Here's WhyJune 9, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $6.92 Million Stock Position in Immunovant, Inc. (NASDAQ:IMVT)June 2, 2025 | marketbeat.comHC Wainwright Estimates Immunovant FY2030 EarningsJune 2, 2025 | marketbeat.comLeerink Partnrs Estimates Immunovant FY2030 EarningsJune 2, 2025 | marketbeat.comImmunovant (NASDAQ:IMVT) Shares Gap Up on Earnings BeatMay 30, 2025 | marketbeat.comImmunovant (NASDAQ:IMVT) Posts Earnings Results, Beats Expectations By $0.08 EPSMay 30, 2025 | marketbeat.comImmunovant, Inc. Reports Strategic Progress and Financial ResultsMay 29, 2025 | tipranks.comImmunovant Stock Rises On Narrower-Than-Expected Q1 Loss: Retail’s Still On The FenceMay 29, 2025 | msn.comImmunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025May 29, 2025 | globenewswire.comImmunovant (IMVT) to Release Earnings on WednesdayMay 29, 2025 | marketbeat.comH.C. Wainwright Keeps Buy Rating on Roivant Sciences (ROIV) StockMay 28, 2025 | msn.comNuveen Asset Management LLC Sells 189,759 Shares of Immunovant, Inc. (NASDAQ:IMVT)May 26, 2025 | marketbeat.comBank of America Corp DE Buys 114,511 Shares of Immunovant, Inc. (NASDAQ:IMVT)May 26, 2025 | marketbeat.comWoodline Partners LP Sells 772,251 Shares of Immunovant, Inc. (NASDAQ:IMVT)May 24, 2025 | marketbeat.comImmunovant, Inc. (NASDAQ:IMVT) Shares Purchased by Two Seas Capital LPMay 23, 2025 | marketbeat.comRafferty Asset Management LLC Trims Stock Holdings in Immunovant, Inc. (NASDAQ:IMVT)May 22, 2025 | marketbeat.comIMVT INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into a Private Placement Transaction by Immunovant, Inc. and Encourages Investors to Contact the FirmMay 21, 2025 | businesswire.comVestal Point Capital LP Makes New Investment in Immunovant, Inc. (NASDAQ:IMVT)May 21, 2025 | marketbeat.comTyro Capital Management LLC Has $3.75 Million Stock Holdings in Immunovant, Inc. (NASDAQ:IMVT)May 20, 2025 | marketbeat.comImmunovant, Inc. (NASDAQ:IMVT) Given Average Rating of "Moderate Buy" by AnalystsMay 20, 2025 | marketbeat.comEnsign Peak Advisors Inc Cuts Position in Immunovant, Inc. (NASDAQ:IMVT)May 19, 2025 | marketbeat.comBNP Paribas Financial Markets Takes Position in Immunovant, Inc. (NASDAQ:IMVT)May 19, 2025 | marketbeat.comRTW Investments LP Purchases New Shares in Immunovant, Inc. (NASDAQ:IMVT)May 18, 2025 | marketbeat.comImmunovant, Inc. (NASDAQ:IMVT) Shares Bought by Northern Trust CorpMay 18, 2025 | marketbeat.comProsight Management LP Sells 64,477 Shares of Immunovant, Inc. (NASDAQ:IMVT)May 17, 2025 | marketbeat.comOccudo Quantitative Strategies LP Makes New Investment in Immunovant, Inc. (NASDAQ:IMVT)May 16, 2025 | marketbeat.comIs Immunovant, Inc. (IMVT) The Most Undervalued Stock With Smart Money Ratings?May 15, 2025 | msn.comOrbimed Advisors LLC Buys New Holdings in Immunovant, Inc. (NASDAQ:IMVT)May 15, 2025 | marketbeat.com34,337 Shares in Immunovant, Inc. (NASDAQ:IMVT) Bought by J. Goldman & Co LPMay 14, 2025 | marketbeat.comGranahan Investment Management LLC Makes New Investment in Immunovant, Inc. (NASDAQ:IMVT)May 13, 2025 | marketbeat.comDimensional Fund Advisors LP Sells 58,463 Shares of Immunovant, Inc. (NASDAQ:IMVT)May 12, 2025 | marketbeat.comRaymond James Financial Inc. Buys Shares of 20,382 Immunovant, Inc. (NASDAQ:IMVT)May 11, 2025 | marketbeat.comDAFNA Capital Management LLC Purchases 56,000 Shares of Immunovant, Inc. (NASDAQ:IMVT)May 10, 2025 | marketbeat.comDeep Track Capital LP Has $148.62 Million Position in Immunovant, Inc. (NASDAQ:IMVT)May 9, 2025 | marketbeat.comHsbc Holdings PLC Invests $780,000 in Immunovant, Inc. (NASDAQ:IMVT)May 7, 2025 | marketbeat.comImmunovant, Inc. (NASDAQ:IMVT) Shares Acquired by Baker BROS. Advisors LPMay 6, 2025 | marketbeat.comBoxer Capital Management LLC Makes New $20.44 Million Investment in Immunovant, Inc. (NASDAQ:IMVT)May 4, 2025 | marketbeat.comImmunovant, Inc. (NASDAQ:IMVT) Shares Sold by Price T Rowe Associates Inc. MDMay 4, 2025 | marketbeat.comAquatic Capital Management LLC Takes Position in Immunovant, Inc. (NASDAQ:IMVT)May 2, 2025 | marketbeat.comEmerald Mutual Fund Advisers Trust Decreases Stock Holdings in Immunovant, Inc. (NASDAQ:IMVT)May 1, 2025 | marketbeat.comThyroid Eye Disease Treatment Market Size (7MM) was ~USD 1,993 Million in 2022 and is projected to increase by 2034, estimates DelveInsightApril 30, 2025 | theglobeandmail.com Get Immunovant News Delivered to You Automatically Sign up to receive the latest news and ratings for IMVT and its competitors with MarketBeat's FREE daily newsletter. Email Address IMVT Media Mentions By Week IMVT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMVT News Sentiment▼0.000.57▲Average Medical News Sentiment IMVT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMVT Articles This Week▼36▲IMVT Articles Average Week Get Immunovant News Delivered to You Automatically Sign up to receive the latest news and ratings for IMVT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SLNO News Today QGEN News Today MRNA News Today ASND News Today VTRS News Today BPMC News Today BBIO News Today VRNA News Today ROIV News Today ELAN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMVT) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunovant, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunovant With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
